<- Go home

Added to YB: 2024-12-02

Pitch date: 2024-09-30

CDNA [bullish]

CareDx, Inc

-33.76%

current return

Author Info

No bio for this author

Company Info

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.

Market Cap

$819.6M

Pitch Price

$31.04

Price Target

N/A

Dividend

N/A

EV/EBITDA

-88.86

P/E

13.12

EV/Sales

1.82

Sector

Biotechnology

Category

growth

Show full summary:
Alger Small Cap Focus Fund Portfolio Holding: CareDx, Inc

CDNA: Transplant diagnostics co beats Q2 rev est on higher reimbursement. CMS coverage change in Aug could boost future growth. Offers pre/post-transplant solutions for heart, kidney, lung. Tests detect acute organ rejection. Strong Q2 performance drove share price up.

Read full article (1 min)